Engineered virus provides impetus in search for HIV vaccine

HOUSTON--(April 13, 2004)--A hybrid gene therapy vector that contains components of two viruses could provide a vehicle for producing a vaccine against a host of diseases, including the human immunodeficiency virus, said researchers from Baylor College of Medicine in a multi-institutional research report that appears online today in the Proceedings of the National Academy of Sciences.

In this work, a vaccine vector has been engineered that uses potent features of adenovirus that normally infects respiratory tissues and of reovirus that infects the mucosal membranes of the gut. To develop this potential vaccine vector, a key protein of reovirus that allows it to enter the gut has been exchanged into adenovirus to retarget this non-infectious gene therapy vector into mucosal surfaces.

"This mucosal targeting vector may prove quite potent for repelling viruses like HIV-1 and infectious bioweapons, since the vast majority of pathogens enter the body at mucosal surfaces," said Dr. Michael Barry, an associate professor in BCM's Center for Cell and Gene Therapy with a joint appointment in the Department of Bioengineering at Rice University.

"We will first test this as an HIV vaccine in mice." said George T. Mercier, a Rice University Bioengineering graduate student working with Barry, who serves as his advisor. "If it's useful for HIV-1, it may be useful for a wide variety of other pathogens since you can put any vaccine gene you want into this vector."

"Beyond its potential as a vaccine vehicle, this hybrid vector will also have utility by allowing us to study the specific interactions of this reovirus protein in the host," said Barry. "This has previously been difficult due to the complex genetics of reovirus. Now we can study these complex interactions using the simpler genetic system provided by the adenoviral vector."

Collaborators include: Terence S. Dermody, Jacquelyn A. Campbell and James D. Chappell of Vanderbilt U

Contact: Lori Williams
Baylor College of Medicine

Page: 1 2

Related biology news :

1. Engineered proteins will lead to synthetic biology
2. Engineered mice point to new target for pain relief
3. Engineered Corn Can Kill Monarch Butterflies
4. Engineered Bacteria Scavenge Heavy Metals
5. Genetically Engineered Mice Exhibit Anxiety, Offering Insight Into Role Of Serotonin In Brain
6. Genetically Engineered Mice Show Characteristic Signs Of Alzheimers, Could Be Ideal Tool For Testing New Therapies
7. Body Building: Tissue Engineered Organs A Heartbeat Away
8. Engineered Neo-Organs For Bladder Replacement
9. Jefferson Researchers First To Create Genetically Engineered Mouse To Study Photoaging
10. Two-Pronged Attack On Immune System Cells Engineered By HIV Gene vpr: Effects Markedly Reversed By Antisteroid Compound RU-486
11. Pacific Northwest team unveils largest virus proteome to date

Post Your Comments:

(Date:5/14/2020)... N.J. (PRWEB) , ... May ... ... SIMPLY – a platform that helps Life Science Manufacturers accurately and easily ... LAUNCH," automating the development of Gross-to-Net models by projecting discounts/rebates to Commercial ...
(Date:5/6/2020)... ... 2020 , ... Sickle Cell Disease Association of America, Inc. (SCDAA) ... the quality, safety, efficacy and cost of red blood cell (RBC) transfusion therapy, are ... and meet its goals. In 2020 Hemanext will collaborate with SCDAA on its educational ...
(Date:5/1/2020)... (PRWEB) , ... April 30, 2020 , ... ... emerging infectious diseases, announced today that it had been awarded a contract from ... the Assistant Secretary for Preparedness and Response at the U.S. Department of Health ...
Breaking Biology News(10 mins):
(Date:5/14/2020)... ... May 13, 2020 , ... ... Future Lab: Optimizing Workflows in the Life Science Lab . The comprehensive ... their lab, from water purification and liquid handling to contamination control. , The ...
(Date:5/5/2020)... ... 04, 2020 , ... Red Nucleus, a leading provider of ... that Informa Training Partners, a life sciences training company acquired by Red Nucleus ... immediately. , “The name change solidifies a stronger presence for Red Nucleus in ...
(Date:5/1/2020)... ... April 30, 2020 , ... ... honoring the businesses, policies, projects, and concepts that are actively engaged and deeply ... living cells, which has taken out the top prize in the Experimental category. ...
(Date:4/22/2020)... ... April 20, 2020 , ... Global molecular diagnostics company ... Omixon’s founder and chairman Dr. Attila Berces returns as CEO. Outgoing CEO Dr. ... 2014 before stepping into the CEO role in 2017. , In concert ...
Breaking Biology Technology:
Cached News: